This is in compromise with the studies reported by Yazar et al. [11] in which patients neoplasia demonstrate superior value of T. gondii IgG and IgM antibodies seropositive (52.9%) considered the control group (20%) [11]. The gene discussed is CD40LG; the disease is neoplasm.